44 / 64
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 6, November/December 2020
324
AFRICA
M,
et al
. Prévalence et caractéristiques des syndromes coronariens aigus
dans une population d’Afrique sub-Saharienne.
Ann Cardiol Angeiol
2016;
65
: 59–63.
12. Kakou-Guikahue M, N’Guetta R, Anzouan-Kacou JB, Kramoh E,
N’Dori A, Ba SA,
et al
. Optimizing the management of acute coronary
syndromes in sub-Saharan Africa: a statement from the AFRICARDIO
2015 consensus team.
Arch Cardiovasc Dis
2016;
109
: 376–383.
13. American Diabetes Association. 2. Classification and diagnosis of
diabetes: standards of medical care in diabetes – 2019.
Diabetes Care
2019;
42
(Suppl 1): S13–S28.
14. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti
F,
et al
. 2015 ESC guidelines for the management of acute coronary
syndromes in patients presenting without persistent ST-segment eleva-
tion: Task Force for the Management of Acute Coronary Syndromes
in Patients Presenting without Persistent ST-Segment Elevation of
the European Society of Cardiology (ESC).
Eur Heart J
2016;
37
(3):
267–315.
15. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS,
et al
. 2016 ESC guidelines for the diagnosis and treatment of acute and
chronic heart failure: the Task Force for the diagnosis and treatment of
acute and chronic heart failure of the European Society of Cardiology
(ESC) developed with the special contribution of the Heart Failure
Association (HFA) of the ESC.
Eur Heart J
2016;
37
(27): 2129–2200.
16. Bahiru E, Temu T, Gitura B, Farquhar C, Huffman MD, Bukachi F.
Presentation, management and outcomes of coronary syndromes: a
registry study from Kenyatta National Hospital in Nairobi, Kenya.
Cardiovasc J Afr
2018;
29
(4): 225–230.
17. Chen P, Chua S, Hung H, Huang C, Lin C, Lai S,
et al
. Admission
hyperglycaemia predicts poorer short- and long-term outcomes after
primary percutaneous coronary intervention for ST-elevation myocar-
dial infarction
. J Diabetes Investig
2014;
5
: 80–86.
18. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendíc S, Rydén L,
et al
. Glucose metabolism in patients with acute myocardial infarction
and no previous diagnosis of diabetes mellitus: a prospective study
.
Lancet
2002;
359
: 2140–2144.
19. Ishihara M. Acute hyperglycaemia in patients with acute myocardial
infarction.
Circ J
2012;
76
: 563–571.
20. Senthinathan A, Kelly V, Dzingina M, Jones D, Baker M, Longson D.
Hyperglycaemia in acute coronary syndromes: summary of NICE guid-
ance.
Br Med J
2011;
343
: 6646.
21. Tansey MJ, Opie LH. Relation between plasma free fatty acids and
arrhythmias within the first twelve hours of acute myocardial infarc-
tion.
Lancet
1983;
2
: 419–422.
22. Abebe W, Mozaffari M. Endothelial dysfunction in diabetes:
Potential application of circulating markers as advanced diagnostic and
prognostic tools.
EPMA J
. 2010;
1
(1): 32–45.
23. Taegtmeyer H, McNulty P, Young ME. Adaptation and maladaptation
of the heart in diabetes: Part I: General concepts.
Circulation
2002;
105
:
1727–1733.
24. Benalia M, Zeller M, Mouhat B, Guenancia C, Yameogo V, Greco C,
et
al.
Glycaemic variability is associated with severity of coronary artery
disease in patients with poorly controlled type 2 diabetes and acute
myocardial infarction.
Diabetes Metab
2019;
45
(5): 446–452.
25. Mi SH, Su G1 Yang HX, Zhou Y, Tian L, Zhang T, Tao H. Comparison
of in-hospital glycaemic variability and admission blood glucose in
predicting short-term outcomes in non-diabetes patients with ST eleva-
tion myocardial infarction underwent percutaneous coronary interven-
tion.
Diabetol Metab Syndr
2017;
9
: 20.
26. Vergès B, Avignon A, Bonnet F, Catargi B, Cattan S, Cosson E,
et al
.
Consensus statement on the care of the hyperglycaemic/diabetic patient
during and in the immediate follow-up of acute coronary syndrome.
Diabetes Metab
2012;
38
(2): 113–127.
27. Ntyintyane LM, Panz VR, Raal FJ, Gill GV. Metabolic syndrome, undi-
agnosed diabetes mellitus and insulin resistance are highly prevalent in
urbanised South African blacks with coronary artery disease.
Cardiovasc
J Sth Afr
2006;
17
(2): 50–55.
28. Wang TY, Newby LK, Chen AY, Mulgund J, Roe MT, Sonel AF,
et al
.
Hypercholesterolemia paradox in relation to mortality in acute coronary
syndrome.
Clin Cardiol
2009;
32
(9): 22–28.
29. N’Guetta R, Ekou A, Yao H, Anzouan-Kacou JB, Gérardin B, Pillière
R,
et al
. Angioplastie coronaire dans les syndromes coronariens aigus
en Côte d’Ivoire: difficultés et résultats.
Ann Cardiol Angeiol
2018;
67
(4):
244–249.
30. Dortimer AC, Shenoy PN, Shiroff RA,
et al
. Diffuse coronary artery
disease in diabetic patients: Fact or fiction?
Circulation
1978;
57
:
133–136.
31. N’Guetta R, Yao H, Ekou A, Séri B, N’Cho-Mottoh MP, Soya E,
et al
.
Coronary artery disease in black African patients with diabetes: Insights
from an Ivorian cardiac catheterization centre.
Arch Cardiovasc Dis
2019;
112
(5): 296–304.
32. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP,
Benedetto U,
et al
. 2018 ESC guidelines on myocardial revasculariza-
tion.
Eur Heart J
2019;
40
(2): 87–165.